These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials. Lioger B, Maillot F, Ternant D, Passot C, Paintaud G, Bejan-Angoulvant T. J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658 [Abstract] [Full Text] [Related]
23. Management of adult idiopathic thrombocytopenic purpura. Nakhoul IN, Kozuch P, Varma M. Clin Adv Hematol Oncol; 2006 Feb; 4(2):136-44, 153. PubMed ID: 16728922 [Abstract] [Full Text] [Related]
24. [Diagnostic approach and treatment of immune thrombocytopenia in adults]. Kolonić SO, Patekar MB, Milunović V. Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250 [Abstract] [Full Text] [Related]
25. Diagnosis and management of immune thrombocytopenia in childhood. Kühne T. Hamostaseologie; 2017 Jan 31; 37(1):36-44. PubMed ID: 27699328 [Abstract] [Full Text] [Related]
26. [Idiopathic thrombocytopenic purpura in children]. Gebauer E, Vijatov G. Med Pregl; 1998 Jan 31; 51(3-4):127-34. PubMed ID: 9611955 [Abstract] [Full Text] [Related]
27. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin. Tarantino MD, Madden RM, Fennewald DL, Patel CC, Bertolone SJ. J Pediatr; 1999 Jan 31; 134(1):21-6. PubMed ID: 9880444 [Abstract] [Full Text] [Related]
30. Contemporary management of primary immune thrombocytopenia in adults. Lakshmanan S, Cuker A. J Thromb Haemost; 2012 Oct 31; 10(10):1988-98. PubMed ID: 22863415 [Abstract] [Full Text] [Related]
31. Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica. De Mattia D, Del Principe D, Del Vecchio GC, Jankovic M, Arrighini A, Giordano P, Menichelli A, Mori P, Zecca M, Pession A. Haematologica; 2000 Apr 31; 85(4):420-4. PubMed ID: 10756369 [Abstract] [Full Text] [Related]
32. Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study. Palau J, Sancho E, Herrera M, Sánchez S, Mingot ME, Upegui RI, Rodríguez Salazar MJ, de la Cruz F, Fernández MC, González López TJ, Hernández JJ, Ríos E, López-Fernández MF, García M, Hernández JÁ, Sanz MA. Hematology; 2017 Sep 31; 22(8):484-492. PubMed ID: 28415913 [Abstract] [Full Text] [Related]
33. The effect of ABO and Rh blood type on the response to intravenous immune globulin (IVIG) in children with immune thrombocytopenic purpura (ITP). Sturgill MG, Nagabandi SR, Drachtman RA, Ettinger AG, Rubin J, Ettinger LJ. J Pediatr Hematol Oncol; 1997 Sep 31; 19(6):523-5. PubMed ID: 9407938 [Abstract] [Full Text] [Related]
34. Update on the management of immune thrombocytopenic purpura in children. Tarantino MD, Bolton-Maggs PH. Curr Opin Hematol; 2007 Sep 31; 14(5):526-34. PubMed ID: 17934363 [Abstract] [Full Text] [Related]
36. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E, Milner R, Ali K, Barnard D, Bernstein M. Lancet; 1994 Sep 10; 344(8924):703-7. PubMed ID: 7915773 [Abstract] [Full Text] [Related]
37. Outcome measures and treatment endpoints other than platelet count in childhood idiopathic thrombocytopenic purpura. Buchanan GR, Adix L. Semin Thromb Hemost; 2001 Jun 10; 27(3):277-85. PubMed ID: 11446661 [Abstract] [Full Text] [Related]